Astec LifeSciences Limited

Astec LifeSciences Limited (ASTEC) is a micro-cap Chemicals company valued at ₹1,584 crore operating in Pesticides & Agrochemicals on the NSE and BSE.

Recent price move

Astec LifeSciences Limited last traded at ₹707.5, down 2.62% on the day.

Recent developments

On 2026-09-30, the promoter holding remained at 71.96%, indicating no significant change in ownership. The company reported a net loss of ₹81 crore for the latest financial year, which is an improvement compared to the prior year's loss of ₹135 crore.

Financial performance

The company's business has improved, with annual net profit narrowing from a loss of ₹135 crore to ₹81 crore, a 17.4 percentage point improvement in net profit margin. However, the latest quarter showed a decline in revenue compared to the same quarter a year earlier, with revenue falling 8.2% to ₹84 crore, while the net loss narrowed from ₹33 crore to ₹19 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 4.06 times book value.

Things to watch

The company continues to report a net loss, with a net profit margin of -18.0%, which is still far from profitability. The revenue growth has been declining over the past five years, with a compound annual growth rate of -4.2%. Additionally, the stock is 24.6% below its 52-week high, indicating a significant drop from recent peak levels.

Where it stands

The company has shown some improvement in reducing its net loss, but remains unprofitable with a net profit margin of -18.0%. The stock is 24.6% below its 52-week high, and revenue growth has been declining over the past five years. The most significant reported figure is the net loss of ₹81 crore for the latest financial year.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.